微信关注
China
Total item
Cart Subtotal
￥ 0.00 “receptor”的搜索结果
31 个项目
每页
-
ITI214 free base
Catalog No. A21947 picomolar PDE1 inhibitorITI-214 (free base) is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). 了解更多 -
GW3965 HCl
Catalog No. A11204 -
Leptomycin B
Catalog No. A20985 nuclear export receptor CRM1 inhibitorLeptomycin B (CI 940; LMB) is a potent inhibitor of the nuclear export of proteins. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue. Leptomycin B is a potent antifungal antibiotic blocking the eukaryotic cell cycle. 了解更多 -
Fexaramine
Catalog No. A21771 FXR agonistFexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity relative to natural compounds. 了解更多 -
RGX-104 free Acid
Catalog No. A21513 LXR agonistRGX-104 free Acid is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene. 了解更多 -
Indeglitazar
Catalog No. A21148 PPAR agonistIndeglitazar is an orally available peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma (γ). 了解更多 -
Arhalofenate
Catalog No. A21135 PPARγ agonistArhalofenate (MBX 102) is a selective partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ, used for the treatment of type 2 diabetes. 了解更多 -
Tesaglitazar
Catalog No. A20891 PPAR alpha/gamma agonistTesaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist that is more potent on PPARγ than on PPARα, with EC50s of 13.4 μM and 3.6 μM for rat PPARα and human PPARα, respectively. 了解更多 -
GNF351
Catalog No. A12609 -
Nidufexor
Catalog No. A12625 -
Cilofexor
Catalog No. A13143 -
Leriglitazone
Catalog No. A18636 PPAR gamma agonistLeriglitazone is a peroxisome proliferator activated receptor (PPAR) gamma agonist. 了解更多 -
MA-0204
Catalog No. A19031 PPARδ modulatorMA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD). 了解更多 -
NXT629
Catalog No. A18771 PPAR-α antagonistNXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively. 了解更多 -
Molindone hydrochloride
Catalog No. A17647 MAO inhibitorMolindone HCl is a D2 dopamine receptor antagonist. It also acts as a MAO inhibitor. 了解更多 -
Etofylline
Catalog No. A17491 PPAR agonistEtofylline, also known as BRN-0251760, is a peroxisome proliferator-activated receptor (PPAR) agonist used to treat respiratory and cardiovascular disorders. Etofylline is often used as a bronchodilator. 了解更多 -
Dyphylline
Catalog No. A10339 Adenosine receptor 拮抗剂Dyphylline是黄嘌呤衍生物，具有支气管扩张药和血管扩张药的作用。 它充当腺苷受体拮抗剂和磷酸二酯酶抑制剂。 了解更多 -
Aminophylline
Catalog No. A10066 Adenosine receptor 拮抗剂Aminophylline是一种非选择性的腺苷受体拮抗剂和磷酸二酯酶抑制剂，能够逆转局部缺血引起的bradyasystole。 了解更多 -
Cyproterone acetate
Catalog No. A11409 Androgen Receptor 拮抗剂Cyproterone acetate是17-羟孕酮的合成衍生物，可作为雄激素受体拮抗剂以及具有弱孕激素和糖皮质激素活性的弱孕激素受体激动剂。 了解更多 -
Bexarotene (LGD1069)
Catalog No. A11094 Retinoid X Receptor LigandBexarotene (LGD1069)是一种高度选择性的类维生素A X受体（RXR）激动剂。 了解更多
31 个项目
每页
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
FILTER BY:
Filtering:
- 分类: Cell Metabolism 删除该内容
购物选项
- 分类
-
- Cytochrome P450 (1)
- PPAR (10)
- PDE (4)
- MAO (1)
- LXR (4)
- FXR (4)
- Retinoid Receptor (3)
- AhR (3)
- CRM1 (1)
- 作用机制
-
- Inhibitor (抑制剂) (4)
- Agonist (激动剂) (19)
- Antagonist (拮抗剂) (5)
- Modulator (调节剂) (2)
ADOOQ 产品质量保证
We promise all products to perform as described.